U.S., July 17 -- ClinicalTrials.gov registry received information related to the study (NCT07706946) titled 'Intravenous Chelators in Lead-Burdened Type 2 Diabetic Nephropathy' on July 12.
Brief Summary: Based on previous basic experiments revealing that patients with type 2 diabetic nephropathy exhibit higher blood lead levels than the general population, this study aims to systematically evaluate the impacts of short-term and long-term blood lead exposure on renal function progression in such patients, so as to provide novel epidemiological evidence for clinical intervention.
Study Start Date: Aug. 01
Study Type: INTERVENTIONAL
Condition:
Lead-Burdened Type 2 Diabetic Nephropathy
Intervention:
DRUG: chelator
Calcium Disodium Edeta...